CovidChloroV1, Main, Exploration, bibRecord, 000D48

Remdesivir (Veklury) for COVID-19.

Identifieur interne : 000D48 ( Main/Exploration ); précédent : 000D47; suivant : 000D49

Remdesivir (Veklury) for COVID-19.

Auteurs :

Source :

The Medical letter on drugs and therapeutics [ 1523-2859 ] ; 2020.

RBID : pubmed:33443491

Descripteurs français

KwdFr :
- AMP (administration et posologie), AMP (analogues et dérivés), AMP (effets indésirables), AMP (usage thérapeutique), Adulte (MeSH), Alanine (administration et posologie), Alanine (analogues et dérivés), Alanine (effets indésirables), Alanine (usage thérapeutique), Antiviraux (administration et posologie), Antiviraux (effets indésirables), Antiviraux (usage thérapeutique), Complications infectieuses de la grossesse (traitement médicamenteux), Essais cliniques comme sujet (MeSH), Essais contrôlés randomisés comme sujet (MeSH), Femelle (MeSH), Grossesse (MeSH), Humains (MeSH), Interactions médicamenteuses (MeSH).
MESH :
- administration et posologie : AMP, Alanine, Antiviraux.
- analogues et dérivés : AMP, Alanine.
- effets indésirables : AMP, Alanine, Antiviraux.
- traitement médicamenteux : Complications infectieuses de la grossesse.
- usage thérapeutique : AMP, Alanine, Antiviraux.
- Adulte, Essais cliniques comme sujet, Essais contrôlés randomisés comme sujet, Femelle, Grossesse, Humains, Interactions médicamenteuses.

English descriptors

KwdEn :
- Adenosine Monophosphate (administration & dosage), Adenosine Monophosphate (adverse effects), Adenosine Monophosphate (analogs & derivatives), Adenosine Monophosphate (therapeutic use), Adult (MeSH), Alanine (administration & dosage), Alanine (adverse effects), Alanine (analogs & derivatives), Alanine (therapeutic use), Antiviral Agents (administration & dosage), Antiviral Agents (adverse effects), Antiviral Agents (therapeutic use), COVID-19 (drug therapy), Clinical Trials as Topic (MeSH), Drug Interactions (MeSH), Female (MeSH), Humans (MeSH), Pregnancy (MeSH), Pregnancy Complications, Infectious (drug therapy), Randomized Controlled Trials as Topic (MeSH).
MESH :
- chemical , administration & dosage : Adenosine Monophosphate, Alanine, Antiviral Agents.
- chemical , adverse effects : Adenosine Monophosphate, Alanine, Antiviral Agents.
- chemical , analogs & derivatives : Adenosine Monophosphate, Alanine.
- chemical , therapeutic use : Adenosine Monophosphate, Alanine, Antiviral Agents.
- drug therapy : COVID-19, Pregnancy Complications, Infectious.
- Adult, Clinical Trials as Topic, Drug Interactions, Female, Humans, Pregnancy, Randomized Controlled Trials as Topic.

PubMed: 33443491

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000487
to stream Main, to step Curation: 000487

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Remdesivir (Veklury) for COVID-19.</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33443491</idno>
<idno type="pmid">33443491</idno>
<idno type="wicri:Area/Main/Corpus">000487</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000487</idno>
<idno type="wicri:Area/Main/Curation">000487</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000487</idno>
<idno type="wicri:Area/Main/Exploration">000487</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Remdesivir (Veklury) for COVID-19.</title>
</analytic>
<series><title level="j">The Medical letter on drugs and therapeutics</title>
<idno type="eISSN">1523-2859</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine Monophosphate (administration & dosage)</term>
<term>Adenosine Monophosphate (adverse effects)</term>
<term>Adenosine Monophosphate (analogs & derivatives)</term>
<term>Adenosine Monophosphate (therapeutic use)</term>
<term>Adult (MeSH)</term>
<term>Alanine (administration & dosage)</term>
<term>Alanine (adverse effects)</term>
<term>Alanine (analogs & derivatives)</term>
<term>Alanine (therapeutic use)</term>
<term>Antiviral Agents (administration & dosage)</term>
<term>Antiviral Agents (adverse effects)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>COVID-19 (drug therapy)</term>
<term>Clinical Trials as Topic (MeSH)</term>
<term>Drug Interactions (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Pregnancy (MeSH)</term>
<term>Pregnancy Complications, Infectious (drug therapy)</term>
<term>Randomized Controlled Trials as Topic (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>AMP (administration et posologie)</term>
<term>AMP (analogues et dérivés)</term>
<term>AMP (effets indésirables)</term>
<term>AMP (usage thérapeutique)</term>
<term>Adulte (MeSH)</term>
<term>Alanine (administration et posologie)</term>
<term>Alanine (analogues et dérivés)</term>
<term>Alanine (effets indésirables)</term>
<term>Alanine (usage thérapeutique)</term>
<term>Antiviraux (administration et posologie)</term>
<term>Antiviraux (effets indésirables)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Complications infectieuses de la grossesse (traitement médicamenteux)</term>
<term>Essais cliniques comme sujet (MeSH)</term>
<term>Essais contrôlés randomisés comme sujet (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Grossesse (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Interactions médicamenteuses (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adenosine Monophosphate</term>
<term>Alanine</term>
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Adenosine Monophosphate</term>
<term>Alanine</term>
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Adenosine Monophosphate</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adenosine Monophosphate</term>
<term>Alanine</term>
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>AMP</term>
<term>Alanine</term>
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>AMP</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
<term>Pregnancy Complications, Infectious</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>AMP</term>
<term>Alanine</term>
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Complications infectieuses de la grossesse</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>AMP</term>
<term>Alanine</term>
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Clinical Trials as Topic</term>
<term>Drug Interactions</term>
<term>Female</term>
<term>Humans</term>
<term>Pregnancy</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Essais cliniques comme sujet</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Femelle</term>
<term>Grossesse</term>
<term>Humains</term>
<term>Interactions médicamenteuses</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33443491</PMID>
<DateCompleted><Year>2021</Year>
<Month>01</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1523-2859</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>62</Volume>
<Issue>1612</Issue>
<PubDate><Year>2020</Year>
<Month>11</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>The Medical letter on drugs and therapeutics</Title>
<ISOAbbreviation>Med Lett Drugs Ther</ISOAbbreviation>
</Journal>
<ArticleTitle>Remdesivir (Veklury) for COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>186-188</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Med Lett Drugs Ther</MedlineTA>
<NlmUniqueID>2985240R</NlmUniqueID>
<ISSNLinking>0025-732X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>3QKI37EEHE</RegistryNumber>
<NameOfSubstance UI="C000606551">remdesivir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>415SHH325A</RegistryNumber>
<NameOfSubstance UI="D000249">Adenosine Monophosphate</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>OF5P57N2ZX</RegistryNumber>
<NameOfSubstance UI="D000409">Alanine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000249" MajorTopicYN="N">Adenosine Monophosphate</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">Veklury</Keyword>
<Keyword MajorTopicYN="Y">adverse effects</Keyword>
<Keyword MajorTopicYN="Y">coronavirus</Keyword>
<Keyword MajorTopicYN="Y">dosage</Keyword>
<Keyword MajorTopicYN="Y">drug interactions</Keyword>
<Keyword MajorTopicYN="Y">efficacy</Keyword>
<Keyword MajorTopicYN="Y">hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="Y">interferon beta</Keyword>
<Keyword MajorTopicYN="Y">lactation</Keyword>
<Keyword MajorTopicYN="Y">lopinavir/ritonavir</Keyword>
<Keyword MajorTopicYN="Y">pregnancy</Keyword>
<Keyword MajorTopicYN="Y">remdesivir</Keyword>
<Keyword MajorTopicYN="Y">safety</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year>
<Month>1</Month>
<Day>14</Day>
<Hour>12</Hour>
<Minute>9</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2021</Year>
<Month>1</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>1</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33443491</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D48 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D48 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:33443491
   |texte=   Remdesivir (Veklury) for COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:33443491" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Remdesivir (Veklury) for COVID-19.

Remdesivir (Veklury) for COVID-19.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki